奥扎格雷钠联合疏血通治疗急性脑梗死的疗效评价及对血清TNF-a、IL-6和hs-CRP水平的影响

奥扎格雷钠联合疏血通治疗急性脑梗死的疗效评价及对血清TNF-a、IL-6和hs-CRP水平的影响
李文;蔡忠平;劳文成
【期刊名称】《上海医药》
【年(卷),期】2016(37)17
【摘要】Objective:To explore the clinical efifcacy of sodium ozagrel combined with Shuxuetong injection in the treatment of acute cerebral infarction and their effect on serum TNF-α, IL-6 and hs CRP levels. Methods:Seventy-two cases of patients with acute cerebral infarction were retrospectively analyzed and divided into a study group (38 cases) and a control group (34 cases) based on the differences of the treatment methods. The control group was treated by conventional treatments including dehydration, antihypertension, anti-platelet aggregation, protection of brain cells, symptomatic and supportive treatment and ozagrel while the study group with Shuxuetong injection on the basis of the control group. The clinical efifcacy and adverse reactions and the changes of serum TNF-α, IL-6 and hs-CRP levels were compared between two groups. Results:The total effective rate and ADL scores were
84.21%and (78.43+8.75) in the study group and 67.64%and (66.54+10.12) in the control group (P<0.05). The contents of serum TNF-alpha, IL-6 and hs-CRP were (2.21+0.36) ng/L and (1.86+0.44), (54.75±3.25) pg/L and (42.36±3.62) pg/L as well as (7.53±3.22) mg/L and (3.19±1.90) mg/L in the
study group and (2.63±0.42) ng/L and (2.14±0.39) ng/L, (60.61±3.69) pg/L and (55.73±3.16) pg/L as well as (10.46±3.41) mg/L and (6.23±2.94) mg/L in the control group 7 and 14 days after treatment, respectively (P<0.05). Conclusion:The clinical efifcacy of sodium ozagrel combined with Shuxuetong injection in the treatment of acute brain infarction is clear. They possess less adverse reactions and can signiifcantly reduce the serum TNF-α, IL-6 and hs-CRP levels and inhibit the inlfammatory reaction in patients.%目的：探究奥扎格雷钠联合疏血通治疗急性脑梗死的临床疗效及对患者血清TNF-a、IL-6和hs-CRP水平的影响。

方法：回顾性分析2013年1月—2015年6月我院收治的急性脑梗死患者72例，根据治疗方式的不同，分为研究组38例和对照组34例。

对照组给予脱水降压、抗血小板凝聚、脑细胞保护及对症支持等常规治疗及奥扎格雷氯化钠注射液治疗，研究组在对照组的基础上加用疏血通注射液。

比较两组患者的临床疗效、不良反应以及治疗前后血清TNF-a、IL-6和hs-CRP水平的变化。

结果：研究组治疗的总有效率和ADL评分为84.21%和（78.43±8.75）分，对照组为67.64%和（66.54±10.12）分（P＜0.05）；研究组治疗7 d、14 d后血清TNF-α、IL-6及hs-CRP的含量分别为（2.21±0.36）ng/L和（1.86±0.44）ng/L、（54.75±3.25）pg/L和（42.36±3.62）pg/L及（7.53±3.22）mg/L和（3.19±1.90）mg/L，而对照组分别为（2.63±0.42）ng/L和（2.14±0.39）ng/L、（60.61±3.69）pg/L和（55.73±3.16）pg/L及（10.46±3.41）mg/L和（6.23±2.94）mg/L（P＜0.05）。

结论：奥扎格雷钠联合疏血通治疗急性脑梗死疗效确切，不良反应少，且还能显著降低急性脑梗死患者血清TNF-a、IL-6和hs-CRP水平，抑制患者机体内的炎症反应。

【总页数】4页(P28-30,44)
【作者】李文;蔡忠平;劳文成
【作者单位】广东省湛江农垦第二医院内科湛江 524272;广东省湛江农垦第二医院内科湛江 524272;广东省湛江农垦第二医院内科湛江 524272
【正文语种】中文
【中图分类】R743.33;R286
【相关文献】
1.阿司匹林联合奥扎格雷钠对急性脑梗死患者血清hs-CRP、FIB、MDA、SOD及CAT表达水平的影响 [J], 董素娟;代晓杰
2.疏血通注射液联合依达拉奉治疗急性脑梗死的临床疗效及对血清Copeptin、NT-proBNP、Hs-CRP和Hcy水平的影响 [J], 廖国平; 邓芳文; 孙德贵; 胡建华; 林敬明; 尹新生
3.疏血通注射液治疗急性脑出血对患者血小板参数及血清IL-6、hs-CRP、TNF-α水平的影响 [J], 梅小龙
4.疏血通注射液治疗急性脑出血对患者血小板参数及血清IL-6、hs-CRP、TNF-α水平的影响 [J], 梅小龙
5.法舒地尔联合丁苯酞治疗老年急性脑梗死的效果及对血清ADPN、hs-CRP和IL-6水平的影响 [J], 王昕莉
因版权原因，仅展示原文概要，查看原文内容请购买。